190 related articles for article (PubMed ID: 9649227)
1. T lymphocyte responses to anti-neutrophil cytoplasmic autoantibody (ANCA) antigens are present in patients with ANCA-associated systemic vasculitis and persist during disease remission.
King WJ; Brooks CJ; Holder R; Hughes P; Adu D; Savage CO
Clin Exp Immunol; 1998 Jun; 112(3):539-46. PubMed ID: 9649227
[TBL] [Abstract][Full Text] [Related]
2. T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG).
Brouwer E; Stegeman CA; Huitema MG; Limburg PC; Kallenberg CG
Clin Exp Immunol; 1994 Dec; 98(3):448-53. PubMed ID: 7994909
[TBL] [Abstract][Full Text] [Related]
3. Antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis after immunisation with bacterial proteins.
Savige J; Nassis L; Cooper T; Paspaliaris B; Martinello P; MacGregor D
Clin Exp Rheumatol; 2002; 20(6):783-9. PubMed ID: 12508769
[TBL] [Abstract][Full Text] [Related]
4. In vitro cytokine production and proliferation of T cells from patients with anti-proteinase 3- and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidase.
Popa ER; Franssen CF; Limburg PC; Huitema MG; Kallenberg CG; Tervaert JW
Arthritis Rheum; 2002 Jul; 46(7):1894-904. PubMed ID: 12124874
[TBL] [Abstract][Full Text] [Related]
5. T cell responses to myeloperoxidase (MPO) and proteinase 3 (PR3) in patients with systemic vasculitis.
Griffith ME; Coulthart A; Pusey CD
Clin Exp Immunol; 1996 Feb; 103(2):253-8. PubMed ID: 8565308
[TBL] [Abstract][Full Text] [Related]
6. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
[TBL] [Abstract][Full Text] [Related]
7. B cell epitope specificity in ANCA-associated vasculitis: does it matter?
van der Geld YM; Stegeman CA; Kallenberg CG
Clin Exp Immunol; 2004 Sep; 137(3):451-9. PubMed ID: 15320893
[TBL] [Abstract][Full Text] [Related]
8. Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission.
Ohlsson S; Wieslander J; Segelmark M
Clin Exp Immunol; 2003 Mar; 131(3):528-35. PubMed ID: 12605707
[TBL] [Abstract][Full Text] [Related]
9. Induction of neutrophil responsiveness to myeloperoxidase antibodies by their exposure to supernatant of degranulated autologous neutrophils.
Hess C; Sadallah S; Schifferli JA
Blood; 2000 Oct; 96(8):2822-7. PubMed ID: 11023517
[TBL] [Abstract][Full Text] [Related]
10. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
Xin G; Zhao MH; Wang HY
Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
[TBL] [Abstract][Full Text] [Related]
11. In vitro T lymphocyte responses to proteinase 3 (PR3) and linear peptides of PR3 in patients with Wegener's granulomatosis (WG).
van der Geld YM; Huitema MG; Franssen CF; van der Zee R; Limburg PC; Kallenberg CG
Clin Exp Immunol; 2000 Dec; 122(3):504-13. PubMed ID: 11122262
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA.
Schönermarck U; Lamprecht P; Csernok E; Gross WL
Rheumatology (Oxford); 2001 Feb; 40(2):178-84. PubMed ID: 11257154
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
Harper L; Cockwell P; Adu D; Savage CO
Kidney Int; 2001 May; 59(5):1729-38. PubMed ID: 11318943
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA).
Talor MV; Stone JH; Stebbing J; Barin J; Rose NR; Burek CL
Clin Exp Immunol; 2007 Oct; 150(1):42-8. PubMed ID: 17614969
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease.
Merkel PA; Polisson RP; Chang Y; Skates SJ; Niles JL
Ann Intern Med; 1997 Jun; 126(11):866-73. PubMed ID: 9163287
[TBL] [Abstract][Full Text] [Related]
16. Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti-proteinase 3 and anti-myeloperoxidase autoantibodies.
Franssen C; Gans R; Kallenberg C; Hageluken C; Hoorntje S
J Intern Med; 1998 Sep; 244(3):209-16. PubMed ID: 9747743
[TBL] [Abstract][Full Text] [Related]
17. [New aspects in ANCA-associated vasculitides].
Lamprecht P
Med Klin (Munich); 2004 Sep; 99(9):518-22. PubMed ID: 15372181
[TBL] [Abstract][Full Text] [Related]
18. Analysis of anti-neutrophil cytoplasmic antibodies (ANCA): frequency and specificity in a sample of 191 homozygous (PiZZ) alpha1-antitrypsin-deficient subjects.
Audrain MA; Sesboüé R; Baranger TA; Elliott J; Testa A; Martin JP; Lockwood CM; Esnault VL
Nephrol Dial Transplant; 2001 Jan; 16(1):39-44. PubMed ID: 11208991
[TBL] [Abstract][Full Text] [Related]
19. Autoreactive T-cell responses to myeloperoxidase in patients with antineutrophil cytoplasmic antibody-associated vasculitis and in healthy individuals.
Seta N; Tajima M; Kobayashi S; Kawakami Y; Hashimoto H; Kuwana M
Mod Rheumatol; 2008; 18(6):593-600. PubMed ID: 18806928
[TBL] [Abstract][Full Text] [Related]
20. Alpha 1-antitrypsin deficiency and anti-proteinase 3 antibodies in anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis.
Savige JA; Chang L; Cook L; Burdon J; Daskalakis M; Doery J
Clin Exp Immunol; 1995 May; 100(2):194-7. PubMed ID: 7743654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
